The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review

Background Exogenous sex steroids within hormonal contraception and menopausal hormone therapy (MHT) have been used for family planning and management of menopausal symptoms, without consideration of their effects on the vaginal microbiota. This is largely because their use predates our understanding of the importance of the vaginal microbiome on human health. We conducted a systematic review (PROSPERO: CRD42018107730) to determine the influence of exogenous sex steroids, stratified by oestrogen-containing or progestin-only types of contraception, and MHT on the vaginal microbiome, as measured by molecular methods. Methods Embase, PubMed and Medline were searched for relevant literature published through to December 1st 2020. Eligible studies reported on the effect of specific exogenous sex steroids on the vaginal microbiome using a molecular method. Data regarding the ‘positive’, ‘negative’ or ‘neutral’ effect of each type of contraceptive or MHT on the vaginal microbiome was extracted and summarised. A positive effect reflected sex steroid exposure that was associated with increased abundance of lactobacilli, a change to, or maintenance of, an optimal vaginal microbiota composition, or a decrease in bacterial diversity (specifically reflecting a low-diversity optimal microbiota state), relative to the control group. An exogenous sex steroid was designated as having a negative effect on the vaginal microbiome if it resulted in opposing effects (i.e. loss of lactobacilli, a non-optimal microbiota state). When no significant change was found, this was considered neutral/inconclusive. Results We identified 29 manuscripts reporting on the effect of exogenous sex steroids on the vaginal microbiome; 25 investigating hormonal contraceptives, and 4 investigating MHT. Oestrogen-containing contraception, particularly reflecting the combined oestrogen and progestin-containing contraceptive pill, had a positive effect on the composition of the vaginal microbiota. Progestin-only contraception, particularly reflecting depo-medroxyprogesterone acetate, had mixed effects on the microbiota. Among post-menopausal women using MHT, exogenous oestrogen applied topically was associated with increased prevalence of lactobacilli. Conclusion Our findings suggest that oestrogen-containing compounds may promote an optimal vaginal microbiota, which could have clinical applications. The impact of progestin-only contraceptives on the vaginal microbiota is less clear; more data is needed to determine how progestin-only contraceptives contribute to adverse reproductive and sexual health outcomes.

[1]  S. Chevalier,et al.  Variability of the response of human vaginal Lactobacillus crispatus to 17β-estradiol , 2021, Scientific Reports.

[2]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. , 2021, Journal of clinical epidemiology.

[3]  E. Plummer,et al.  Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review. , 2021, PloS one.

[4]  R. Heffron,et al.  The Complex Link between the Female Genital Microbiota, Genital Infections, and Inflammation , 2021, Infection and Immunity.

[5]  R. Heffron,et al.  Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition , 2020, PLoS pathogens.

[6]  U. Karaoz,et al.  Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial , 2020, Nature Communications.

[7]  T. Hallett,et al.  Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa , 2020, Journal of the International AIDS Society.

[8]  The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. , 2020, Menopause.

[9]  S. Garland,et al.  Sex is associated with the persistence of non‐optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study , 2020, BJOG : an international journal of obstetrics and gynaecology.

[10]  C. Deveney,et al.  Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise , 2020, mSphere.

[11]  J. Ravel,et al.  Characterization of the Vaginal Microbiome in Women of Reproductive Age From 5 Regions in Brazil , 2020, Sexually transmitted diseases.

[12]  R. McClelland,et al.  Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate , 2020, PloS one.

[13]  G. Gloor,et al.  Effect of Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women , 2020, Nutrients.

[14]  R. Gugasyan,et al.  Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota , 2020, Frontiers in Cellular and Infection Microbiology.

[15]  Maria I. Rodriguez,et al.  Hormonal contraception and HIV acquisition among women: an updated systematic review , 2020, BMJ Sexual & Reproductive Health.

[16]  S. Delany-Moretlwe,et al.  Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota. , 2020, AIDS.

[17]  Courtney K. Robinson,et al.  Associations between dietary micronutrient intake and molecular-Bacterial Vaginosis , 2019, Reproductive Health.

[18]  D. Coetzee,et al.  Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study , 2019, PeerJ.

[19]  P. Gajer,et al.  The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection , 2019, mBio.

[20]  J. H. van de Wijgert,et al.  Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota , 2019, BMC Microbiology.

[21]  Courtney K. Robinson,et al.  P591 The effect of hormonal contraception on the vaginal microbiota over 2 years , 2019, Poster Presentations.

[22]  Douglas J. Taylor,et al.  HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial , 2019, The Lancet.

[23]  S. Proll,et al.  P587 Association between vaginal bacteria and HIV acquisition risk among african women participating in the VOICE study , 2019, Poster Presentations.

[24]  P. Gajer,et al.  Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings , 2019, PloS one.

[25]  T. Hope,et al.  Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection , 2019, PloS one.

[26]  J. Hocking,et al.  Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial , 2019, Scientific Reports.

[27]  R. Kaul,et al.  The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission , 2019, AIDS research and human retroviruses.

[28]  R. Froissart,et al.  Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics , 2019, Scientific Reports.

[29]  Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2019 Winter Meeting, February 26-March 2, 2019, InterContinental Hotel, Miami, Florida. , 2019, Neurourology and urodynamics.

[30]  Stuart M. Brown,et al.  Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women , 2019, Emerging microbes & infections.

[31]  M. Surette,et al.  Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice , 2019, Disease Models & Mechanisms.

[32]  D. Molenaar,et al.  Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota , 2018, Microbiome.

[33]  A. LaCroix,et al.  Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial , 2018, Menopause.

[34]  J. H. van de Wijgert,et al.  Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women , 2018, PloS one.

[35]  J. Ravel,et al.  Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid , 2018, mSphere.

[36]  S. Witkin.  Limitations of treating pregnant women based solely on vaginal pH , 2018, BJOG : an international journal of obstetrics and gynaecology.

[37]  L. Meyn,et al.  Impact of contraceptive initiation on vaginal microbiota , 2018, American journal of obstetrics and gynecology.

[38]  Melis N. Anahtar,et al.  Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity. , 2018, Cell host & microbe.

[39]  M. Watson,et al.  The Madness of Microbiome: Attempting To Find Consensus “Best Practice” for 16S Microbiome Studies , 2018, Applied and Environmental Microbiology.

[40]  Anna K. Blakney,et al.  Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females , 2017, Infection and Immunity.

[41]  Xiang Zhan,et al.  Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis , 2017, Menopause.

[42]  J. H. van de Wijgert,et al.  The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands , 2017, PloS one.

[43]  L. McKinnon,et al.  Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women , 2017, Science.

[44]  R. Cone,et al.  The role of lactic acid production by probiotic Lactobacillus species in vaginal health. , 2017, Research in microbiology.

[45]  D. Anderson,et al.  Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition , 2017, Mucosal Immunology.

[46]  Jennifer M. Fettweis,et al.  Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. , 2017, Contraception.

[47]  M. Vaneechoutte,et al.  Lactobacillus iners: Friend or Foe? , 2017, Trends in microbiology.

[48]  R. McClelland,et al.  4: Associations between hormonal contraceptive methods and the vaginal microbiota , 2016 .

[49]  L. Forney,et al.  Unraveling the Dynamics of the Human Vaginal Microbiome , 2016, The Yale journal of biology and medicine.

[50]  L. Forney,et al.  Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis , 2016, Scientific Reports.

[51]  C. Morrison,et al.  Injectable Progestin‐Only Contraception is Associated With Increased Levels of Pro‐Inflammatory Cytokines in the Female Genital Tract , 2015, American journal of reproductive immunology.

[52]  C. Bassis,et al.  P06.07 The effects of contraception on the vaginal microbiota , 2015 .

[53]  R. Cone,et al.  Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis , 2015, Front. Physiol..

[54]  S. Lebeer,et al.  Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health , 2015, Front. Physiol..

[55]  J. H. van de Wijgert,et al.  The Impact of Hormonal Contraception and Pregnancy on Sexually Transmitted Infections and on Cervicovaginal Microbiota in African Sex Workers , 2015, Sexually transmitted diseases.

[56]  S. Bailey,et al.  Effects of an Over-the-Counter Vented Mouthguard on Cardiorespiratory Responses to Exercise and Physical Agility , 2015, Journal of strength and conditioning research.

[57]  S. Delany-Moretlwe,et al.  Correlates of the molecular vaginal microbiota composition of African women , 2015, BMC Infectious Diseases.

[58]  B. Herold,et al.  Research Gaps in Defining the Biological Link between HIV Risk and Hormonal Contraception , 2014, American journal of reproductive immunology.

[59]  P. Mirmonsef,et al.  The Barrier to HIV Transmission Provided by Genital Tract Lactobacillus Colonization , 2014, American journal of reproductive immunology.

[60]  S. Simavlı,et al.  The impact of copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: A prospective study , 2014, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[61]  R. Cone,et al.  Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota , 2013, PloS one.

[62]  J. Hocking,et al.  Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis , 2013, PloS one.

[63]  M. Settles,et al.  Vaginal microbiome changes with levonorgestrel intrauterine system placement. , 2013, Contraception.

[64]  K. Curtis,et al.  Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. , 2013, The Lancet. Infectious diseases.

[65]  C. Morrison,et al.  Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission , 2013, AIDS.

[66]  L. Forney,et al.  Influence of Vaginal Bacteria and d- and l-Lactic Acid Isomers on Vaginal Extracellular Matrix Metalloproteinase Inducer: Implications for Protection against Upper Genital Tract Infections , 2013, mBio.

[67]  R. Cone,et al.  Vaginal concentrations of lactic acid potently inactivate HIV , 2013, The Journal of antimicrobial chemotherapy.

[68]  R. Cone,et al.  In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide , 2011, BMC infectious diseases.

[69]  R. Brotman,et al.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. , 2010, The Journal of infectious diseases.

[70]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[71]  L. Meyn,et al.  Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis , 2009, Menopause.

[72]  G. Reid,et al.  Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes. , 2008, Microbes and infection.

[73]  Michael C. Wendl,et al.  Argonaute—a database for gene regulation by mammalian microRNAs , 2005, BMC Bioinformatics.

[74]  C. Castelo-Branco,et al.  Management of post-menopausal vaginal atrophy and atrophic vaginitis. , 2005, Maturitas.

[75]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[76]  G. Reid,et al.  Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. , 2005, Canadian journal of microbiology.

[77]  G. Reid,et al.  Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[78]  M. Krohn,et al.  Lower Genital Tract Infection and Endometritis: Insight Into Subclinical Pelvic Inflammatory Disease , 2002, Obstetrics and gynecology.

[79]  K. Whaley,et al.  Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. , 2001, Human reproduction.

[80]  M. S. St. Louis,et al.  A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[81]  M. Hickey,et al.  Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism , 2016 .

[82]  Myron S. Cohen,et al.  The role of sexually transmitted diseases in HIV transmission , 2004, Nature Reviews Microbiology.